-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

322.O2.6 322. Disorders of Coagulation or Fibrinolysis: Hemophilia: Treatment and Inhibitors

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Hemophilia, Bleeding Disorders, Anemias, Biological, Animal models, Diseases, Bleeding and Clotting, Non-Biological, Hemostasis, Therapies, Genetic Disorders, Pediatric, Adverse Events, Biological Processes, coagulant drugs, Young Adult, Study Population, Clinically relevant, immune mechanism
Monday, December 7, 2020: 7:00 AM-8:30 AM
Tyler W. Buckner, MD, MSc, University of Colorado School of Medicine and Glaivy Batsuli, MD, Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta and Emory University
Buckner: Spark: Consultancy; Takeda: Consultancy; Kedrion: Consultancy; uniQure: Consultancy; Tremeau Pharmaceuticals: Consultancy; Biomarin: Consultancy; Bayer: Consultancy; CSL Behring: Consultancy; Novo Nordisk: Consultancy; American Thrombosis and Hemostasis Network: Membership on an entity's Board of Directors or advisory committees; Genentech: Consultancy. Batsuli: Octapharma: Other: Advisory board ; Bayer: Other: Advisory board ; Genentech: Other: Advisory board .
7:00 AM

Radoslaw Kaczmarek*, Thais Bertolini* and Roland W Herzog, PhD

Pediatrics, Indiana University School of Medicine, Indianapolis, IN

7:15 AM

Vincent P. Diego, Ph.D.1,2*, Bernadette W. Luu, B.S., M.T. (CLS)1,2,3*, Alexis Garza, B.S.2*, Marco Hofmann, M.S.4*, Marcio A. Almeida, Ph.D.1,2*, Jerry S. Powell, M.D.3,5, Long V. Dinh, Ph.D.3*, Raja Rajalingam, Ph.D.6*, Juan M Peralta, M.S.1,2*, Satish Kumar, Ph.D.1,2*, Eli Fine, Ph.D.3*, Joanne E. Curran, Ph.D.1,2*, Miguel A. Escobar, M.D.7*, Sarah Williams-Blangero, Ph.D.1,2*, Eugene Maraskovsky, Ph.D.8*, John Blangero, Ph.D.1,2* and Tom E. Howard, M.D., Ph.D.1,2,3,9*

1South Texas Diabetes and Obesity Institute, The University of Texas Rio Grande Valley, Brownsville, TX
2Department of Human Genetics, School of Medicine, The University of Texas Rio Grande Valley, Brownsville, TX
3Haplogenics, Brownsville, TX
4Research, CSL Behring GmbH, Marburg, Germany
5Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, The University of California at Davis, Davis, CA
6Immunogenetics and Transplantation Laboratory, Department of Surgery, School of Medicine, The University of California at San Francisco, San Francisco, CA
7University of Texas Health Science Center, Houston, TX
8Research, Bio21 Institute, CSL Limited, Melbourne, Australia
9Department of Pathology and Laboratory Medicine, VA Valley Coastal Bend Healthcare System, Harlingen, TX

7:30 AM

Christoph Koenigs1*, Margareth C. Ozelo2, Amy Dunn3, Roshni Kulkarni, MD4, Beatrice Nolan, FRCPath5*, Simon A. Brown6*, Raina Liesner7*, Michele Schiavulli8*, Sriya Gunawardena9*, Sutirtha Mukhopadhyay10*, Deepthi Jayawardene9*, Bent Winding11* and Manuel Carcao12

1Department of Pediatrics and Adolescent Medicine, University Hospital Frankfurt, Frankfurt, Germany
2University of Campinas, São Paulo, Brazil
3Nationwide Children's Hospital, Columbus, OH
4Michigan State University, East Lansing, MI
5Children Health Ireland at Crumlin, Dublin, Ireland
6Queensland Children’s Hospital, South Brisbane, QLD, Australia
7Great Ormond Street Hospital, London, United Kingdom
8A.O.R.N. Santobono-Pausilipon, Naples, Italy
9Sanofi, Waltham, MA
10Sanofi, Gent, Belgium
11Swedish Orphan Biovitrum AB (Sobi), Stockholm, Sweden
12Hospital for Sick Children, Toronto, Canada

7:45 AM

Tyler W. Buckner, MD, MSc1, Shannon L Carpenter, MD2, Stacy E. Croteau, MD3, Adam Cuker, MD, MS4, Nabil Daoud, MA5*, Christine L Kempton, MD, MSc6, Lynn M Malec, MD7, Thomas W. McLean, MD8*, Leslie J. Raffini, MD9, Janice M Staber, MD10, Michael Wang, MD11, Crystal Watson, BS5*, Ayesha Zia12 and Michael Recht, MD, PhD5,13

1Divisions of Hematology and Pediatric Hematology/Oncology, Hemophilia and Thrombosis Center, University of Colorado School of Medicine, Aurora, CO
2Children's Mercy Hospital, Kansas City, MO
3Children's Hospital Boston, Boston, MA
4Department of Medicine and Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
5American Thrombosis and Hemostasis Network, Rochester, NY
6Emory University, Atlanta, GA
7Blood Research Institute, Versiti, Milwaukee, WI
8Wake Forest University School of Medicine, Winston Salem, NC
9Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA
10University of Iowa Stead Family Children’s Hospital, Iowa City, IA
11Anschutz Medical Campus, University of Colorado, School of Medicine, Hemophilia and Thrombosis Center, Aurora, CO
12University of Southwestern Medical Center, Dallas, TX
13The Hemophilia Center, Oregon Health and Sci. Univ., Portland, OR

8:00 AM

Steven W. Pipe, MD1, John Pasi, MB, ChB, PhD, FRCP, FRCPath, FRCPCH2, Toshko Lissitchkov3*, Margaret V. Ragni, MD, MPH4, Claude Négrier5, Qifeng Yu6*, Stacey Poloskey7*, Baisong Mei8 and Shauna R. Andersson8*

1Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor, MI
2Royal London Haemophilia Centre, Barts and the London School of Medicine and Dentistry, London, United Kingdom
3Department of Chemotherapy, Hemotherapy and Hereditary Blood Diseases at Clinical Hematology Clinic, Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Bulgaria
4Department of Medicine - Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA
5Hôpital Cardiologique Louis Pradel, Lyon, France
6Albireo Pharma, Inc., Boston, MA
7Sanofi, Waltham, MA
8Sanofi, Cambridge, MA

*signifies non-member of ASH